References

1.Asafo-Agyei KO, Samant H. Hepatocellular carcinoma [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559177/ 

​

2.Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. 10th ed. Philadelphia, Pennsylvania Elsevier; 2018. 

​

3.Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson AB, et al. Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival. JNCI: Journal of the National Cancer Institute. 2017 Mar 31;109(9). 

​

4.Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology [Internet]. 2009 Jan 1 [cited 2020 Apr 14];136(1):138–48. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18848939?dopt=Abstract 

​

5.Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, et al. Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology [Internet]. 2011 May [cited 2019 Jun 5];9(5):428–33. Available from: https://www.cghjournal.org/article/S1542-3565(11)00114-5/pdf 

​

6.Testino G, Leone S, Borro P. Alcohol and hepatocellular carcinoma: A review and a point of view. World Journal of Gastroenterology : WJG [Internet]. 2014 Nov 21;20(43):15943–54. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239482/ 

​

7.Hilal Unsal, Cengiz Yakicier, Christophe Marcais, Kew M, Volkmann M, Zentgraf H, et al. Genetic heterogeneity of hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 1994 Jan 18;91(2):822–6. 

​

8.Wikipedia Contributors. Hepatocellular carcinoma [Internet]. Wikipedia. Wikimedia Foundation; 2019. Available from: https://en.wikipedia.org/wiki/Hepatocellular_carcinoma 

​

9.Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, et al. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology. 2015 Mar 20;62(2):440–51. 

​

10.Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England Journal of Medicine [Internet]. 1996 Mar 14;334(11):693–9. Available from: https://pubmed.ncbi.nlm.nih.gov/8594428/ 

​

11.Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul JL, et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology. 2018 Jul;69(1):182–236. 

​

12.Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, et al. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology [Internet]. 1984 Jun;86(6):1404–9. Available from: https://pubmed.ncbi.nlm.nih.gov/6201411/ 

​

13.D’Onofrio M, Faccioli N, Zamboni G, Malagò R, Caffarri S, Fattovich G, et al. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels. La Radiologia medica [Internet]. 2008 Oct;113(7):978–91. Available from: https://pubmed.ncbi.nlm.nih.gov/18779929/ 

​

14.Jain D. Tissue Diagnosis of Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology. 2014 Aug;4:S67–73. 

​

15.Matsumoto Y, Suzuki T, Asada I, Ozawa K, Tobe T, Honjo I. Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels. Cancer. 1982 Jan 15;49(2):354–60. 

​

16.Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. Journal of Hepatology. 2007 Aug 14;47(5):684–90.